Skip to content

The effect of Pilates treatment on the physical function and immunity of patients with HTLV-related nervous system disease

Impact of Pilates treatment on the clinical and immunological profile of patients with Paraparesis tropical spasticity / lymphotropic virus-associated myelopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2ctm5q
Enrollment
Unknown
Registered
2019-11-12
Start date
2015-05-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Type 1 Lymphotropic T Virus

Interventions

Thirteen PET / MAH patients were selected, who performed 20 Pilates sessions twice a week for 10 weeks, lasting approximately 50 minutes. Data collection was performed at three moments (1st AV - initi
stabilization of the spine and hip. In the walking patients, active stretching of the anterior and posterior chain, stretching of the lumbar square and rotator muscles of the spine was performed, alwa
Then, it was used to strengthen the abdominal muscles, the extensors of the spine, all movements of the lower limbs, upper limbs, especially in the shoulder movements, but always with the intention of
Other
E02.779.474

Sponsors

Universidade Federal do Pará
Lead Sponsor
Universidade Federal do Pará
Collaborator

Eligibility

Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria selected individuals of both sexes; aged over 18 years old; with confirmed HTLV-1 infection and clinical diagnosis of HAM/TSP

Exclusion criteria

Exclusion criteria: Individuals who were under 18 years old or who had any disease that prevented treatment by Pilates exercises or presenting any disease that could influence the patients’ symptoms and unrelated to HAM/TSP; such as bone tuberculosis and the occurrence of pain caused by disc herniation or fibromyalgia; were excluded

Design outcomes

Primary

MeasureTime frame
Expected Outcome 1: Improvement in pain level, as assessed by visual analog scale (VAS), with at least 50% decrease in pain after 10 sessions of intervention, and checking if improvement remains after 10 weeks without Pilates.;Observed outcome 1: Significant improvement in pain level, assessed by visual analog scale (VAS), with p-value equal to 0.00117. Data collected before the intervention and 10 weeks after the intervention. However, there was a significant reduction in pain level improvement, p-value equal to 0.0431 after 10 sessions without Pilates. ;Expected Outcome 2: Improvement of static and dynamic balance, as assessed by the Tinnet scale after the 10 intervention sessions, and whether the improvement remains after 10 weeks without Pilates.;Observed outcome 2: Significant improvement in static and dynamic equilibrium, assessed by the Tinnet scale, with p-value equal to 0.0431. Data collected before the intervention and 10 weeks after the intervention. However, there was no stastitic difference after they were 10 weeks without Pilates, p-value equal to 0.0629.;Expected Outcome 3: Improvement of mobility, assessed by Timed Up and Go, after the 10 sessions of the intervention, and verifying if improvement remains after 10 weeks without Pilates.;Observed outcome 3: Improved mobility with a significant difference in the decrease in time to perform the Time Up and Go test after 10 weeks of intervention with a p-value of 0.0117. However, an increase in time was observed after 10 weeks without Pilates treatment, p-value 0.0431.;Expected Outcome 4: Improvement in quality of life after the 10 intervention sessions, and checking if improvement remains after 10 weeks without Pilates.;Observed outcome 4: Significant improvement in quality of life regarding pain item, assessed by SF-36 life questionnaire after 10 weeks of intervention with p-value equal to 0.0117. However, an increase in time was observed after 10 weeks without Pilates treatment, p-value 0.1797. As for

Secondary

MeasureTime frame
No Secondary Outcomes Expected

Countries

Brazil

Contacts

Public ContactAltair Klautau

Universidade Federal do Pará

altairklautau@yahoo.com.br+55(91)32018412

Outcome results

None listed

Source: REBEC (via WHO ICTRP)